These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9498709)

  • 1. In vivo infusion of anti-LFA-1 and anti-CD2 antibodies prevents graft failure after HLA partially incompatible bone marrow transplantation in children with high risk acute lymphoblastic leukaemia.
    Cavazzana-Calvo M; Jabado N; Bordigoni P; Michel G; Haddad E; Mechinaud F; Landman-Parker J; Leblanc T; Plouvier E; Baruchel A; Stephan JL; Souillet G; Vilmer E; Wijdenes J; Le Deist F; Fischer A
    Leuk Lymphoma; 1997 Dec; 28(1-2):103-12. PubMed ID: 9498709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. Société Française de Greffe de Moelle Osseuse.
    Cavazzana-Calvo M; Bordigoni P; Michel G; Esperou H; Souillet G; Leblanc T; Stephan JL; Vannier JP; Mechinaud F; Reiffers J; Vilmer E; Landman-Parker J; Benkerrou M; Baruchel A; Pico J; Bernaudin F; Bergeron C; Plouvier E; Thomas C; Wijdenes J; Lacour B; Blanche S; Fischer A
    Br J Haematol; 1996 Apr; 93(1):131-8. PubMed ID: 8611446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: a European Group for Immunodeficiency/European Group for Bone Marrow Transplantation report.
    Fischer A; Friedrich W; Fasth A; Blanche S; Le Deist F; Girault D; Veber F; Vossen J; Lopez M; Griscelli C
    Blood; 1991 Jan; 77(2):249-56. PubMed ID: 1985691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome.
    Green A; Clarke E; Hunt L; Canterbury A; Lankester A; Hale G; Waldmann H; Goodman S; Cornish JM; Marks DI; Steward CG; Oakhill A; Pamphilon DH
    Blood; 1999 Oct; 94(7):2236-46. PubMed ID: 10498594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic bone marrow transplantation with T cell-depleted partially matched related donors for advanced acute lymphoblastic leukemia in children and adults: a comparative matched cohort study.
    Fleming DR; Henslee-Downey PJ; Romond EH; Harder EJ; Marciniak E; Munn RK; Messino MJ; Macdonald JS; Bishop M; Rayens MK; Thompson JS; Foon KA
    Bone Marrow Transplant; 1996 Jun; 17(6):917-22. PubMed ID: 8807094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of EBV-induced B-lymphoproliferative disorder by ex vivo marrow B-cell depletion in HLA-phenoidentical or non-identical T-depleted bone marrow transplantation.
    Cavazzana-Calvo M; Bensoussan D; Jabado N; Haddad E; Yvon E; Moskwa M; Tachet des Combes A; Buisson M; Morand P; Virion JM; Le Deist F; Fischer A
    Br J Haematol; 1998 Nov; 103(2):543-51. PubMed ID: 9827933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.
    Al-Kasim FA; Thornley I; Rolland M; Lau W; Tsang R; Freedman MH; Saunders EF; Calderwood S; Doyle JJ
    Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of a CD18/anti-LFA1 monoclonal antibody infusion to prevent graft rejection in leukemic patients receiving T-depleted allogeneic bone marrow transplantation.
    Baume D; Kuentz M; Pico JL; Beaujean F; Cordonnier C; Vernant JP; Hayat M; Bernard A
    Transplantation; 1989 Mar; 47(3):472-4. PubMed ID: 2564220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center.
    Ozsahin H; Le Deist F; Benkerrou M; Cavazzana-Calvo M; Gomez L; Griscelli C; Blanche S; Fischer A
    J Pediatr; 1996 Aug; 129(2):238-44. PubMed ID: 8765621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma.
    Anasetti C; Amos D; Beatty PG; Appelbaum FR; Bensinger W; Buckner CD; Clift R; Doney K; Martin PJ; Mickelson E
    N Engl J Med; 1989 Jan; 320(4):197-204. PubMed ID: 2643045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study.
    Eapen M; Rubinstein P; Zhang MJ; Stevens C; Kurtzberg J; Scaradavou A; Loberiza FR; Champlin RE; Klein JP; Horowitz MM; Wagner JE
    Lancet; 2007 Jun; 369(9577):1947-54. PubMed ID: 17560447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo infusion of anti LFA-1 antibody in HLA non-identical bone marrow transplantation in children: serum concentrations and biological effects.
    Perez N; Le Deist F; Chatenoud L; Chanteloup N; Griscelli C; Fischer A
    Bone Marrow Transplant; 1989 Jul; 4(4):379-84. PubMed ID: 2673457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partially mismatched related-donor bone marrow transplantation for pediatric patients with acute leukemia: younger donors and absence of peripheral blasts improve outcome.
    Godder KT; Hazlett LJ; Abhyankar SH; Chiang KY; Christiansen NP; Bridges KD; Lee CG; Geier SS; Goon-Johnson KS; Gee AP; Pati AR; Parrish RS; Henslee-Downey PJ
    J Clin Oncol; 2000 May; 18(9):1856-66. PubMed ID: 10784626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of bone marrow and cardiac graft rejection in an H-2 haplotype disparate mouse combination by an anti-LFA-1 antibody.
    Cavazzana-Calvo M; Sarnacki S; Haddad E; De Coene C; Calise D; Yvon E; Cerf-Bensussan N; Fischer A
    Transplantation; 1995 Jun; 59(11):1576-82. PubMed ID: 7778173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission.
    Saarinen-Pihkala UM; Gustafsson G; Ringdén O; Heilmann C; Glomstein A; Lönnerholm G; Abrahamsson J; Bekassy AN; Schroeder H; Mellander L;
    J Clin Oncol; 2001 Jul; 19(14):3406-14. PubMed ID: 11454889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose T-cell lymphocyte infusion combined with marrow T-cell depletion as prophylaxis of acute graft vs host disease for HLA identical sibling bone marrow transplantation.
    Cahn JY; Deconinck E; Tiberghien P; Brion A; Racadot E; Deschaseaux M; Angonin R; Voillat L; Vuillier J; Fontan J; Morel P; Cordonnier JM; Comparot S; Woronoff-Lemsi MC; Hervé P
    Hematol Cell Ther; 1999 Apr; 41(2):31-7. PubMed ID: 10344550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.
    Aversa F; Tabilio A; Velardi A; Cunningham I; Terenzi A; Falzetti F; Ruggeri L; Barbabietola G; Aristei C; Latini P; Reisner Y; Martelli MF
    N Engl J Med; 1998 Oct; 339(17):1186-93. PubMed ID: 9780338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.